UBAP2L Antibody

What cellular compartments does UBAP2L localize to, and how can this be detected using antibodies?

UBAP2L demonstrates dynamic localization patterns that vary with cellular conditions. While previously considered primarily a stress granule (SG) protein, recent research demonstrates that UBAP2L also localizes to processing bodies (PBs) under specific conditions and contributes to PB biogenesis . For immunofluorescence detection:

• Use specific anti-UBAP2L antibodies (such as those recognizing the epitope between residues 400-450)

• Co-stain with established markers:

  • SG markers: G3BP1

  • PB markers: HEDLS or DDX6

• Apply stress conditions (e.g., arsenite treatment) to visualize redistribution patterns

• Examine both arsenite-induced SGs and constitutive or stress-induced PBs

UBAP2L's dual localization pattern provides important insights into its role in modulating the formation and interaction of these biomolecular condensates under stress conditions .

What are the recommended antibody-based techniques for studying UBAP2L protein-protein interactions?

UBAP2L serves as a central node in RNA-protein interaction networks spanning both stress granules and processing bodies. To study its protein interactions:

• Immunoprecipitation (IP): Use anti-UBAP2L antibodies to pull down native complexes from cellular extracts. This approach has successfully demonstrated interactions with BMI1 and can be adapted to identify other binding partners .

• Reverse IP approach: Express tagged UBAP2L (e.g., Flag-UBAP2L) and perform immunoprecipitations using anti-tag antibodies, followed by western blotting for potential interacting partners .

• Co-localization analysis: Combine immunofluorescence using anti-UBAP2L antibodies with staining for suspected interaction partners like G3BP1 (for SGs) and DDX6 (for PBs) .

These methodological approaches have revealed UBAP2L's association with both SG-specific protein G3BP1 and the PB-essential protein DDX6, positioning it as a potential mediator between these distinct biomolecular condensates .

How can antibodies help distinguish between different UBAP2L isoforms or modified forms?

UBAP2L exists in multiple forms that can be distinguished using specific antibodies. When interpreting western blot results:

• The antibody recognizing epitopes between residues 400-450 (such as A300-533A) can detect both the full-length UBAP2L and a shorter form .

• Some antibodies (like A300-534A) may only detect the full-length form .

• Use appropriate molecular weight markers to identify:

  • Full-length UBAP2L (~120 kDa)

  • Shorter UBAP2L isoforms (migrating more quickly on SDS-PAGE)

When studying post-translational modifications, consider combining immunoprecipitation with specific modification-detecting antibodies (phospho-, ubiquitin-, or SUMO-specific antibodies) to reveal regulation mechanisms affecting UBAP2L's function in stress response pathways.

How can researchers design experiments to delineate UBAP2L's differential roles in stress granules versus processing bodies?

Based on recent findings that UBAP2L contributes to both SG and PB biology, researchers should implement careful experimental designs to distinguish its compartment-specific functions:

• Temporal analysis of UBAP2L recruitment:

  • Use time-lapse imaging with fluorescently-tagged or antibody-detected UBAP2L

  • Track its recruitment to SGs and PBs during stress induction and recovery

  • Compare timing with known SG (G3BP1) and PB (HEDLS, DDX6) markers

• Selective compartment disruption:

  • Use cycloheximide to disrupt processing bodies while preserving stress granules

  • Apply G3BP1/2 knockdown to inhibit stress granule formation

  • Monitor UBAP2L redistribution using antibody detection in each condition

• Domain-specific mutant analysis:

  • Create constructs lacking specific UBAP2L domains (UBA, RGG, DUF)

  • Perform rescue experiments in UBAP2L knockout cells

  • Use antibodies to detect interactions and localization patterns of each mutant

This approach has revealed that UBAP2L not only contributes to SG formation as previously known but also "contributes to PB biogenesis and SG–PB interactions, and can nucleate hybrid granules containing SG and PB components in cells" .

What methodological considerations should be addressed when using UBAP2L antibodies in cancer research applications?

UBAP2L has been implicated in hepatocellular carcinoma (HCC) progression, requiring specific considerations when using antibodies for cancer research:

• Tissue-specific validation:

  • Test antibody specificity against both normal and HCC tissue samples

  • Include appropriate positive and negative controls

  • Verify specificity using UBAP2L knockdown/knockout controls

• Quantitative analysis protocols:

  • For immunohistochemistry (IHC): Implement standardized scoring systems

  • Develop consistent thresholds for categorizing "high" versus "low" expression

  • Correlate with clinicopathological features using multivariate analysis

• Experimental controls for mechanistic studies:

  • Include matched normal tissues for expression comparison

  • Use multiple antibody clones to confirm findings

  • Complement protein-level detection with mRNA analysis techniques

These approaches have revealed UBAP2L overexpression in HCC, with high expression correlating with unfavorable prognosis, suggesting its potential as a biomarker and therapeutic target .

How can researchers accurately assess UBAP2L's role in biomolecular condensate interactions using quantitative imaging techniques?

Advanced imaging analysis of UBAP2L's role requires sophisticated quantification approaches:

• Colocalization quantification methodology:

  • Calculate Pearson's correlation coefficients between UBAP2L and SG/PB markers

  • Measure Manders' overlap coefficients to determine percentage overlap

  • Implement object-based colocalization analysis for granule-specific measurements

• Granule property quantification:

  • Number of granules per cell

  • Size distribution analysis

  • Intensity measurements within granules

  • Distance measurements between different granule types

• Dynamic analysis protocols:

  • Fluorescence recovery after photobleaching (FRAP) to measure protein mobility

  • Single molecule tracking to determine UBAP2L residence time in different condensates

  • Live-cell imaging during stress induction and recovery

Implementation of these methods has revealed that "UBAP2L overexpression increases the association between PBs and SGs, causing closely docking PBs and/or forming a hybrid granule in which distinct PB-like foci surround or may even be contained within a large granule" .

What are common technical challenges when using UBAP2L antibodies in immunoprecipitation experiments?

Researchers working with UBAP2L antibodies for immunoprecipitation may encounter several technical challenges:

• Cross-reactivity concerns:

  • UBAP2 (UBAP2L's homolog) shows elevated levels in UBAP2L knockout cells

  • Verify antibody specificity against both proteins

  • Include appropriate knockout/knockdown controls

• Buffer optimization requirements:

  • UBAP2L participates in RNA-protein complexes that may be sensitive to buffer conditions

  • Test different lysis buffers (varying salt concentrations, detergents)

  • Consider using RNase treatment in parallel samples to distinguish RNA-dependent interactions

• Detection of transient interactions:

  • UBAP2L mediates dynamic interactions between stress granules and processing bodies

  • Consider crosslinking approaches to capture transient interactions

  • Implement UBAP2L overexpression systems for enhanced detection sensitivity

Successful immunoprecipitation protocols have been used to confirm interactions between UBAP2L and proteins like BMI1 , and similar approaches can be adapted to investigate its role in SG-PB interactions.

How should researchers interpret contradictory findings regarding UBAP2L localization patterns?

Resolving contradictory observations about UBAP2L localization requires systematic analysis:

• Cell type-specific variations:

  • Compare UBAP2L localization across different cell types (HeLa, U2OS, primary cells)

  • Document baseline expression levels in each system

  • Note differences in stress response pathways between cell types

• Stress condition variables:

  • Different stressors (arsenite, heat shock, osmotic stress) may induce distinct localization patterns

  • Duration and intensity of stress affects granule dynamics and composition

  • Recovery periods show different kinetics for granule assembly/disassembly

• Technical considerations:

  • Fixation methods significantly impact condensate preservation

  • Antibody accessibility may vary between compartments

  • Detection sensitivity thresholds affect visualization of low-abundance pools

Research has shown that UBAP2L "is not solely an SG protein but also localizes to PBs in certain conditions" , explaining some apparently contradictory observations in earlier literature.

What controls should be implemented when evaluating UBAP2L antibody specificity in knockdown/knockout systems?

Rigorous validation of UBAP2L antibodies requires comprehensive controls:

• Genetic control panel:

  • UBAP2L knockout cells (complete absence of target)

  • UBAP2L knockdown cells (reduced expression)

  • Rescue models (re-expression in knockout background)

  • Wild-type cells (positive control)

• Expression system controls:

  • Inducible systems (e.g., doxycycline-regulated) to create expression gradients

  • Tagged vs. untagged UBAP2L to distinguish antibody detection from tag detection

  • Domain deletion mutants to map epitope recognition

• Analytical validation approaches:

  • Western blotting showing expected molecular weight bands

  • Immunofluorescence pattern consistency with reported localizations

  • Mass spectrometry confirmation of immunoprecipitated proteins

Such validation is particularly important given the observation that "UBAP2 levels are elevated in U2OS UBAP2L KO cells" , suggesting compensatory mechanisms that could complicate interpretation of knockdown phenotypes.

How can UBAP2L antibodies be utilized to investigate its role in the protein-RNA interaction network during stress response?

UBAP2L's position as a central node in the RNA-protein interaction network offers opportunities for network-level investigations:

• RNA-protein complex isolation techniques:

  • RNA immunoprecipitation (RIP) using UBAP2L antibodies

  • Crosslinking immunoprecipitation (CLIP) to identify direct RNA binding sites

  • Proximity labeling approaches to map the UBAP2L-associated proteome during stress

• Sequential immunoprecipitation strategy:

  • First IP: Isolate UBAP2L-containing complexes

  • Second IP: Pull down specific SG or PB markers from the first IP

  • Analyze composition of these sequential isolates to identify shared components

• Functional readouts:

  • Translation efficiency measurements

  • mRNA stability assessments

  • Stress recovery kinetics

This approach builds on findings that UBAP2L "associates with polysomes and modulates translation" under normal conditions but redistributes during stress, potentially serving as a scaffold for RNA-protein interactions in biomolecular condensates .

What methodological approaches can reveal the mechanistic role of UBAP2L in cancer progression?

To elucidate UBAP2L's contributions to cancer development, researchers should consider:

• Expression correlation analysis:

  • Use antibodies for tissue microarray analysis across tumor stages

  • Correlate UBAP2L levels with:

    • Clinicopathological features (tumor size, staging, metastasis)

    • Patient survival outcomes

    • Treatment response markers

• Mechanistic pathway investigation:

  • Study UBAP2L's relationship to epithelial-mesenchymal transition (EMT) markers

  • Examine interaction with snail1 regulation pathways

  • Assess impact on angiogenesis markers

• In vivo model systems:

  • Conditional knockout mouse models

  • Xenograft studies with UBAP2L manipulation

  • Patient-derived organoids with UBAP2L modulation

Previous research has established that "UBAP2L is overexpressed in HCC, and patients with high UBAP2L expression had unfavorable prognosis" , suggesting its potential value as both a prognostic marker and therapeutic target.

How can researchers integrate UBAP2L antibody-based detection with biomolecular condensate research methods?

The emergent field of biomolecular condensate research requires integrative approaches:

• Phase separation assessment techniques:

  • In vitro reconstitution of UBAP2L-containing condensates

  • Measurement of condensate material properties (viscosity, molecular exchange rates)

  • Correlative light and electron microscopy to characterize ultrastructure

• Multi-modal detection strategy:

  • Combine antibody detection with RNA visualization techniques

  • Implement live-cell reporters alongside fixed-cell antibody staining

  • Correlate condensate composition with functional outputs

• Computational analysis framework:

  • Develop image analysis pipelines specific to biomolecular condensates

  • Implement machine learning approaches for pattern recognition

  • Create predictive models for condensate behavior based on composition

This integrated approach can help elucidate how UBAP2L "mediates SG:PB docking, and nucleates hybrid granules containing both SG and PB proteins" as part of the "protein–RNA network model of biocondensate formation" .

What antibody-based approaches can distinguish functional consequences of different UBAP2L domain mutations?

UBAP2L contains multiple functional domains that contribute differentially to its activity. To investigate domain-specific functions:

• Domain-specific mutant panel creation:

  • UBA domain deletion or point mutations

  • RGG domain alterations

  • DUF region modifications

  • Combinations of domain mutations

• Functional assessment methodology:

  • Stress granule formation capacity (size, number, composition)

  • Processing body interaction potential

  • RNA binding capability

  • Protein partner interaction profiles

• Quantitative comparisons:

  • Stress granule formation efficiency

  • PB association metrics

  • Translation regulatory impact

These approaches have revealed domain-specific contributions to UBAP2L function, including that "The RGG binds several mRNA-bound complexes... and has been reported to be required for SG formation" while "The DUF region is required for G3BP to bind to UBAP2L... and is also important for SG formation" .

How should researchers design control experiments when analyzing UBAP2L's homologous compensation mechanisms?

UBAP2L and its homolog UBAP2 may exhibit compensatory expression patterns that complicate research interpretation:

• Expression monitoring protocol:

  • Measure both UBAP2L and UBAP2 levels in all experimental conditions

  • Use antibodies specific to each protein

  • Implement qRT-PCR to assess transcriptional compensation

• Double knockdown/knockout strategy:

  • Create UBAP2L single knockdown/knockout

  • Generate UBAP2 single knockdown/knockout

  • Develop double knockdown/knockout systems

  • Compare phenotypes across all conditions

• Rescue experiment design:

  • Reintroduce UBAP2L into knockout cells

  • Test UBAP2 overexpression in UBAP2L-deficient cells

  • Assess functional complementation potential

This approach has revealed that unlike some homologous protein pairs that demonstrate redundancy, "UBAP2L uniquely contributes to SG formation—as well as to PB formation and association with SGs" despite the elevation of UBAP2 levels in UBAP2L knockout cells.